ImmuCell (ICCC) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced as a webcast with all directors, officers, and key employees introduced and present.

• April 13, 2026, set as record date; notice and proxy statement mailed April 24, 2026.

• Quorum established with over 81% of outstanding shares represented by proxy.

Board and executive committee updates

• One employee director, Timothy Fiori, announced he is not running for re-election and will soon end his director role.

Shareholder proposals

• Six items of business presented: election of directors, advisory vote on executive compensation, approval of 2025 Stock Option and Incentive Plan, amendment to certificate of incorporation (Exculpation Amendment), ratification of Wipfli LLP as auditor, and opportunity for shareholder comments.